Last reviewed · How we verify
NCT00943813
Assessment of Comskil Training Through Videorecording and Patient Surveys
trial testing video-recording and completing a survey in Comskil Training in 55 participants. Completed in 1 August 2016.
1 August 2016
Quick facts
| Lead sponsor | Memorial Sloan Kettering Cancer Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 55 |
| Start date | 1 May 2009 |
| Primary completion | 1 August 2016 |
| Estimated completion | 1 August 2016 |
| Sites | 1 location across United States |
Drugs / interventions tested
- video-recording and completing a survey
Conditions studied
- Comskil Training — all drugs for Comskil Training →
Sponsor
Memorial Sloan Kettering Cancer Center — full company profile →
Who can join
19 and older, any sex, with Comskil Training. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
To obtain data from patients about their satisfaction with the fellows' communication and their perception of the fellows' use of communication skills.
Time frame: 1 year
Sponsor's own description
At Memorial Sloan-Kettering Cancer Center the investigators want to provide the best care to their patients. One way to do this is to evaluate the ways that doctors communicate with patients. To this end, the Department of Psychiatry and Behavioral Sciences runs a Communication Skills Training and Research Laboratory. One goal of this laboratory is to evaluate doctor-patient communication and provide training in how to improve the quality of this communication. Invitation to participate in this pilot project does not mean that a problem with communication has been identified in your doctor's practice. Rather, it is because your doctor and the fellow working with your doctor have agreed to cooperate with us as the investigators develop strategies to train physicians, nurses and other clinical personnel to communicate with cancer patients in as effective and sensitive a manner as possible.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT00943813
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Memorial Sloan Kettering Cancer Center trials
Trials by the same sponsor.
- NCT07566377 — Cord Blood Transplantation in Children and Young Adults With Blood Cancer · Phase 2 · recruiting
- NCT07507643 — A Study of Methylprednisolone in People Having Liver Surgery · Phase 3 · recruiting
- NCT07483307 — A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer · Phase 2 · recruiting
- NCT07459673 — HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term · Phase 2 · recruiting
- NCT07449195 — A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00943813 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center
- Last refreshed: 15 August 2016
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00943813.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing